StockWatch
·

PUNJAB CHEMICALS AND CROP PROTECTION LTD.-$

BSE: 506618

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
328.95
-5.2%+26.8%
Expenditure
310.23
-2.1%+29.9%
Net Profit
13.89
-37.3%-20.1%
OPM %
9.13%
-2.64pp-0.84pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0097.19194.39291.58388.77Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Punjab Chemicals Q2 FY27: consolidated PAT -27% YoY on margin squeeze, revenue +28%

agrochemicals · margin compression · raw material costs

ResultsQ2 FY2703 Nov 20263 minMetals & Mining

8.7% growth won't reach 15–20%—the math requires a strong H2

revenue growth miss · guidance credibility · MoU delays

Result verdictFollow-upQ1 FY2719 Aug 20266 minMetals & Mining

Weak Q1 growth masks H2 ambitions; guidance intact but under pressure

new products · supply chain fragility · monsoon weakness

TranscriptDeep diveQ1 FY2719 Aug 20266 minMetals & Mining
Latest
Board Meeting3 Nov, 1:38 pm

Punjab Chemicals Q2 FY27: consolidated PAT -27% YoY on margin squeeze, revenue +28%

Punjab Chemicals and Crop Protection's consolidated PAT fell 27.4% YoY to ₹13.46 Cr (₹18.54 Cr a year ago) and 39.0% QoQ (₹22.07 Cr in Q1 FY27), even as consolidated revenue from operations grew 28.0% YoY to ₹326.70 Cr, though it slipped 5.9% QoQ from ₹347.24 Cr. Basic EPS came in at ₹10.98 versus ₹15.12 a year ago and ₹18.00 last quarter. Standalone PAT of ₹13.89 Cr fell a comparatively milder 20.1% YoY, pointing to an added drag from the Belgian subsidiary, SD Agchem (Europe) NV, at the consolidated level. There were no exceptional items in either the current or year-ago quarter, so the decline is entirely on operating performance, not one-offs. The compression sits on the gross-margin line: cost of materials consumed rose to 62.1% of revenue (₹202.75 Cr) from 55.5% a year ago (₹141.57 Cr), outpacing the 28% topline growth and dragging the EBITDA margin (OPM) down to 9.05% from 11.75% in Q1 FY27 and 10.28% a year ago. Finance costs compounded the squeeze, up 50% YoY to ₹5.67 Cr, as the company leaned more on debt: current borrowings jumped to ₹212.79 Cr from ₹104.95 Cr at FY26-end and non-current borrowings to ₹71.75 Cr from ₹37.42 Cr. Net profit margin fell to 4.12% from 7.27% YoY and 6.34% in Q1 FY27. On guidance, management's FY27 target of 15-20% revenue growth (to ₹1,185-1,236 Cr from a ₹1,030 Cr base) remains on track — H1 FY27 consolidated revenue of ₹673.94 Cr is up 17.3% YoY, inside that band. But the EBITDA margin trajectory is moving the wrong way: management had guided a gradual climb to 15% over 2-3 years from a ~12% base, and this quarter printed 9.05%, below even that starting point. We found no analyst consensus for this quarter — Punjab Chemicals carries thin formal coverage with no published revenue/PAT estimates — so the print can't be graded against street numbers, and the company issued no accompanying press release with this filing. Trade receivables more than doubled to ₹453.92 Cr from ₹203.50 Cr at FY26-end, driving H1 operating cash flow to a negative ₹99.40 Cr versus a positive ₹82.96 Cr a year ago and funding the higher borrowings and finance costs above. Separately, the company disclosed a ₹44.96 Cr IGST refund litigation win in August 2026, which is not reflected as income in this quarter's P&L.

3 Nov 2026, 01:38 pm

Corporate Events

Board MeetingPUNJABCHEM
2026
3Nov

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingPUNJABCHEM
2026
31Jul

Board Meeting

The 50th Annual General Meeting (AGM) of the Company will be…

BSE Filing ↗
DividendPUNJABCHEM
2026
17Jul

₹3 / share

BSE Filing ↗
Board MeetingPUNJABCHEM
2024
28Oct

Board Meeting

Consideration and Approval Of Unaudited (Standalone And Cons…

BSE Filing ↗
Board MeetingPUNJABCHEM
2024
1Aug

Board Meeting

Consider and approve the unaudited (standalone and consolida…

BSE Filing ↗
Board MeetingPUNJABCHEM
2024
6May

Board Meeting

Agenda of the meeting

BSE Filing ↗
Board MeetingPUNJABCHEM
2024
6Feb

Board Meeting

Consider and approve the unaudited (standalone and consolida…

BSE Filing ↗
Board MeetingPUNJABCHEM
2023
26Oct

Board Meeting

Consider and approve the unaudited (standalone and consolida…

BSE Filing ↗